TrialThe oncologist2025

Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25.

Coline Montégut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.